250 words): 17 18 Prostaglandins (PGs) are lipid signaling molecules with numerous physiologic functions, 19 including pain/inflammation, fertility, and cancer. PGs are produced downstream of 20 cyclooxygenase (COX) enzymes, the targets of non-steroidal anti-inflammatory drugs 21 (NSAIDs). In numerous systems, PGs regulate actin cytoskeletal remodeling, however, their 22 mechanisms of action remain largely unknown. To address this deficiency, we undertook a 23 pharmaco-genetic interaction screen during late-stage Drosophila oogenesis. Drosophila 24 oogenesis is as an established model for studying both actin dynamics and PGs. Indeed, during 25 Stage 10B, cage-like arrays of actin bundles surround each nurse cell nucleus, and during Stage 26 11, the cortical actin contracts, squeezing the cytoplasmic contents into the oocyte. Both of these 27 cytoskeletal properties are required for follicle development and fertility, and are regulated by 28
Introduction 40
Many physiological functions, including pain/inflammation, reproduction, heart 41 health/disease, and cancer, are mediated by lipid signals termed prostaglandins (PGs) (Tootle, 42 2013) . PGs are produced at their site of action by cyclooxygenase (COX) enzymes, which are 43 inhibited by non-steroidal anti-inflammatory drugs (NSAIDs). One cellular target of PGs is the 44 actin cytoskeleton (Halbrugge et al., 1990; Nolte et al., 1991; Kawada et al., 1992;  Drosophila oogenesis provides a powerful model for uncovering the mechanisms by 51 which PGs regulate actin remodeling (Spracklen and Tootle, 2015) . Actin-dependent 52 morphogenic events necessary for follicle development ( Figure 1A) are regulated by the 53 coordinated activity of numerous actin binding proteins [reviewed in (Hudson and Cooley, 54 2002) ]. There are 14 stages of follicle development. Each follicle consists of 16 germline-derived 55 cells -an oocyte and 15 support cells, termed nurse cells -and ~1,000 somatically-derived 56 follicle cells. During Stage 10B (S10B), cage-like arrays of parallel actin filament bundles 57 rapidly extend from the nurse cell membranes toward the nuclei (Guild et al., 1997; Huelsmann 58 et al., 2013) . These bundles hold the nuclei in place during Stage 11 (S11), when the nurse cells 59 undergo a rapid actomyosin-based contraction to transfer their cytoplasmic contents into the 60 expanding oocyte in a process termed nurse cell dumping (Wheatley et al., 1995) . Nurse cell 61 dumping requires PGs, as loss of the Drosophila COX-like enzyme Pxt blocks this process 62 (Tootle and Spradling, 2008) . Specifically, PGs are required for bundle formation, cortical actin 63 integrity, and cellular contraction (Tootle and Spradling, 2008; Groen et al., 2012) . 64
Multiple lines of evidence indicate PGs directly regulate actin remodeling. First, mRNA 65 levels of actin regulators are unchanged in pxt mutants (Tootle et al., 2011) . This has been verified at the protein level for a number of actin binding proteins (Groen et al., 2012; Spracklen 67 et al., 2014) . Second, pharmacologic disruption of PG signaling acutely disrupts actin 68 remodeling (Tootle and Spradling, 2008 ), suggesting that PGs likely post-translationally regulate 69 actin binding proteins to rapidly modulate actin remodeling. Together these data led us to 70 hypothesize that PG signaling coordinates the activities of multiple actin regulators to promote 71 both actin remodeling during S10B and cellular contraction during S11. 72
Here we present the results of a pharmaco-genetic interaction screen to identify actin 73 binding proteins functioning downstream of PG signaling during S10B-11 of Drosophila 
Fly husbandry 83
Fly stocks were maintained at 21°C on standard cornmeal-agar-yeast food. Flies were fed 84 with wet yeast paste daily and aged for 3-5 days for in vitro follicle maturation (IVEM) assays 85 and ovary analyses, including immunofluorescence and immunoblotting. y 1 w 1 (yw) was used as 86 the wild-type control in experiments. The sources of stocks used in the pharmaco-genetic 87 interaction screen are indicated in Table 1 . 88
In vitro follicle maturation (IVEM) 89 IVEM assays were performed as previously described (Tootle and Spradling, 2008; 90 Spracklen and Tootle, 2013). Briefly, for each genotype analyzed, whole ovaries were dissected 91 out of mated adult females in room temperature IVEM media (10% heat inactivated fetal bovine 92 serum (FBS) (Atlanta Biologicals, Flowery Branch, GA, USA), 1X penicillin/streptomycin 93 (100X penicillin/streptomycin, Gibco, Life Technologies, Carlsbad, CA, USA), in Grace's insect 94 media (Lonza, Walkersville, MD, USA)) into a 9-well glass plate using forceps. Ovaries were 95 immediately transferred to a clean well with fresh IVEM media and Stage 10B (S10B) follicles 96 were isolated using dissecting needles mounted in pin vises and transferred to a clean well. Once 97 20-30 S10B follicles per condition were isolated, they were transferred to a clean well in a 24-98 well plate. Any IVEM media transferred with the follicles was gently aspirated using a pulled 99
Pasteur pipette and immediately replaced with 1 mL of IVEM media containing vehicle only 100 (3µl of 100% ethanol per 1 mL of IVEM media) or 1.5mM aspirin (3µl of 0.5M aspirin (Cayman 101
Chemical, Ann Arbor, MI, USA) in 100% ethanol per 1 mL of IVEM media). Treated follicles 102 were allowed to mature overnight at room temperature. The assay was scored by determining the 103 percentage of follicles that completed nurse cell dumping in each condition. This was determined 104 by assessing whether the follicles stalled at S10B or whether they progressed to Stage 11 (S11), 105 12 (S12), or 13/14 (S13/14) based on overall follicle morphology ( Figure 1A ). Follicles scored as 106 S10B or S11 were considered to have not completed nurse cell dumping, while follicles that 107 reached S12 or S13/14 were considered to have completed nurse cell dumping. 108
109

Screen analysis 110
In order to compare genotypes across the screen, we calculated a dumping index (% 111 follicles dumping in 1.5mM aspirin/% follicle dumping in control media) for each replicate. 112
Average dumping indices and standard deviations for each experimental genotype and their 113 corresponding controls are reported in Table 1 . To aid in the identification of potential 114 interactions in this screen, we focused on differences in the dumping index between experimental 115 genotypes and wild-type controls by normalizing the data. To do this, we set the dumping index 116 for wild-type controls to zero and normalized the corresponding experimental dumping indices 117 by subtracting the wild-type dumping index from that of the experimental group for each 118 individual experiment. The average normalized dumping index, and their standard deviation, are 119 plotted in Figure 2 . For the purpose of this screen, we arbitrarily defined strong interactors as 120 those showing a response of greater than three standard deviations from wild-type controls, weak 121 interactors as those showing a response between one and three standard deviations from wild-122 type controls, and non-interactors showing a response of less than one standard deviation from 123 wild-type controls in their ability to modify sensitivity to COX inhibition. For statistical 124 analyses, we used unpaired t tests to compare means between experimental and control groups. 125
Graphs generated and statistical comparisons made using Prism8 (GraphPad Software, La Jolla, 126 CA, USA). 127 128
Western blots 129
Approximately 5 whole ovary pairs were dissected in room temperature Grace's insect 130 media (Lonza, Walkersville, MD, USA or Thermo Fisher Scientific, Waltham, MA), transferred 131 to a 1.5ml microcentrifuge tube containing 50µL of Grace's media, an equal volume of 2X SDS 132 Sample Buffer was added and the tissue lysed by grinding with a plastic pestle. Western blots 133 were performed using standard methods. The following primary antibodies were used: mouse 
Pharmaco-genetic interaction screen 180
To identify actin regulators and interacting proteins acting downstream of PG signaling 181 during S10B of Drosophila oogenesis, a pharmaco-genetic interaction screen was undertaken. 182
This screen took advantage of the following: 1) S10B follicles mature to S14 in in vitro culture 183 conditions ( Figure 1A Tootle, 2013), and 3) multiple mutant alleles of most actin regulators and interacting proteins are 186 readily available. In this screen, we hypothesized that if a particular actin regulator were a 187 downstream target of PG signaling, then reduced levels of that actin regulator (i.e., through 188 heterozygosity for strong alleles or homozygosity for weak alleles) would enhance or suppress 189 the inhibition of nurse cell dumping and subsequent follicle maturation due to COX inhibitor 190 treatment. For example, if PG signaling positively regulates Protein X to promote actin 191 remodeling during S10B, then heterozygosity for a strong allele of protein x would be expected 192 to enhance follicle sensitivity to COX inhibition ( Figure 1B ). However, if PG signaling 193 negatively regulates Protein Y to promote actin remodeling during S10B, then heterozygosity for 194 a strong allele of protein y would be expected to suppress follicle sensitivity to COX inhibition 195 ( Figure 1C ). In contrast, reduced levels of an actin binding protein that is not a downstream 196 target of PG signaling during S10B would not be expected to modify follicle sensitivity to COX 197 inhibition ( Figure 1D ). 198
Based on this rationale, we conducted the first pass of a pharmaco-genetic interaction 199 screen using a concentration of aspirin (1.5mM) empirically determined to reproducibly inhibit 200 ~50% of a population of wild-type S10B follicles from completing nurse cell dumping in culture 201 (Tootle and Spradling, 2008) . Using this dose of aspirin ensured we could readily observe both 202 suppression and enhancement of follicle sensitivity to COX inhibition. For each genotype tested, 203 isolated S10B follicles were cultured overnight in either vehicle-treated or aspirin-treated media. 204
We then determined the ratio of the percentage of follicles completing nurse cell dumping in 205 aspirin treated media to the percentage of follicles completing nurse cell dumping in control 206 media for each genotype analyzed (subsequently referred to as the dumping index). Follicles in 207 S10B-11 were considered to have not completed dumping, while those in S12-14 were scored as 208 completing nurse cell dumping ( Figure 1A ). In order to control for potential fluctuations in 209 aspirin concentration (i.e., solvent evaporation) and any inter-experiment variability, wild-type 210 (yw) controls were included in each experiment. Using this approach, we would expect wild-type 211 follicles to exhibit a dumping index of ~0.5, indicating half of the population of S10B follicles 212 failed to complete nurse cell dumping in aspirin treated media. Experiments in which the wild-213 type dumping index was less than 0.4 or greater than 0.6 were excluded from further analyses. 214
We observed an average dumping index of 0.505 (±0.054) for the inclusive data set of all wild-215 type controls (n=59). Aggregate data for all genotypes analyzed and their respective wild-type 216 controls, including the number of trials (n), the average dumping index, and their standard 217 deviation (SD), are summarized in Table 1 . 218
Identifying interactors 219
To aid in the identification of potential interactors in this screen, we wanted to focus on 220 the differences in dumping index between wild-type control and experimental groups. To 221 achieve this, the dumping index for wild-type controls were set to zero and normalized 222 Figure 3A) . 287
The ena 210 allele contains a missense mutation (A97V) within the EVH1 domain ( Figure 3A Figure 3C ). In contrast, heterozygosity for ena 210 , a 296 localization defective allele, strongly enhances follicle sensitivity to COX inhibition. We find 297 that heterozygosity for ena 210 results in a dumping index of 0.192 (±0.135 SD, n=5) compared to 298 0.467 (±0.049 SD, n=11) for wild-type controls (p=<0.0001) (Table 1 and Figure 3C ). 299
While multiple alleles fail to show an interaction, the ena 210 allele strongly suppresses 300 follicle sensitivity to COX inhibition in our pharmaco-genetic interaction screen. There are a 301 number of potential explanations for this finding. It is possible that this allele-specific interaction 302 could be due to genetic background effects that are specific to the ena 210 allele. Given that the 303 ena 23 and ena 210 alleles were generated in the same genetic background and have both been 304 recombined onto the same FRT bearing chromosome, genetic background effects are unlikely to 305 account for the observed differences. It is more likely the allele-specific interaction we observe is 306 due to the nature of alleles tested. Unlike ena GC1 , ena GC5 , ena DG14706 and ena EY13131 , which are predicted to result in decreased Ena levels, the ena 23 and ena 210 alleles produce stable mutant 308 protein products. Therefore, while heterozygosity for ena GC1 , ena GC5 , ena DG14706 , or 309 homozygosity for ena EY13131 would be expected to result in decreased Ena levels, heterozygosity 310 for ena 23 , and ena 210 would be expected to result in a mixture of both wild-type and mutant 311 protein. Indeed, western blot analysis reveals that total Ena levels are similarly mildly reduced in 312 ena GC1 , ena GC5 , ena DG14706 , ena 23 , and ena 210 heterozygotes and ena EY13131 homozygotes (~80% of 313 wild-type controls) ( Figure 3B ). Because the protein product encoded by ena 23 lacks a 314 tetramerization domain, we hypothesize that heterozygosity for ena GC1 , ena GC5 , ena DG14706 , or 315 ena 23 have similar net effects-namely, a mild reduction in functional Ena levels. In contrast, we 316 hypothesize heterozygosity for ena 210 may result in a stronger effect on Ena function, as the 317 mutant protein would be capable of forming tetramers with wild-type Ena. It is possible that such 318 an interaction may result in a partial dominant-negative effect that more strongly impacts 319 functional Ena levels. 320
The observation that heterozygosity for the ena 210 allele strongly sensitizes follicles to 321 the effects of COX inhibition suggests that PG signaling may regulate parallel actin filament 322 bundle formation during S10B, at least in part, by modulating Ena localization. Supporting this 323 idea, using immunofluorescence and confocal microscopy we previously found Ena localization 324 to the barbed ends of actin filament bundles and nurse cell membranes during S10B is reduced in 325 formation during S10B is one cause of the bundle defects observed in pxt mutants. Together 333 these data suggest PG signaling may be required to promote appropriate Ena localization and/or 334 activity during S10B. Exactly how this regulation is achieved remains unclear, but is likely 335 through post-translational mechanisms. One intriguing means by which PGs may regulate Ena 336 activity is through controlling Fascin. Indeed, Fascin has be shown to promote Ena processivity, 337 increasing filament elongation (Winkelman et al., 2014; Harker et al., 2019) . Another 338 mechanism by which PGs may regulate Ena is discussed below. 339
Reduced Cp strongly sensitizes follicles to the effects of COX inhibition 340
The pharmaco-genetic interaction we observed with Ena led us to ask whether reduced The pharmaco-genetic interaction screen identified MRLC as a strong enhancer of 384 follicle sensitivity to COX inhibition. We tested three MRLC alleles. sqh AX3 is a null allele 385 derived from a 5kb genomic deletion removing most of the sqh locus (Jordan and Karess, 1997) . sqh EY09875 is the result of a P-element insertion upstream of the sqh translation start site. We also 387 tested a large chromosomal deficiency, Df(1)5D, that removes 51 loci, including sqh. As 388 expected all three alleles are homozygous lethal. In our assay, we find heterozygosity for sqh 389 enhances follicle sensitivity to COX inhibition, with heterozygosity for sqh AX3 resulting in a 390 dumping index of 0.266 (±0.072 SD, n=3; p=0.0010), heterozygosity for sqh EY09875 resulting in a 391 dumping index of 0.294 (±0.159 SD, n=4; p=0.0118), and heterozygosity for DF(1)5D resulting 392 in a dumping index of 0.374 (±0.255 SD, n=3; p=0.2127) (Table 1 and Figure 4A ). These data 393 suggest PGs normally promote MRLC activity. MRLC is required for nurse cell contraction 394 during S11, as germline loss of MRLC blocks nurse cell dumping but does not cause actin 395 bundle defects (Wheatley et al., 1995) . While loss of Pxt causes severe actin bundle defects, 396 unlike other mutants lacking actin bundles, the nurse cell nuclei do not plug the ring canals; this 397 finding indicates that contraction fails in the absence of Pxt (Tootle and Spradling, 2008; Groen 398 et al., 2012) . Given the pharmaco-genetic interaction, we hypothesize PGs activate MRLC to 399 drive nurse cell contraction required for nurse cell dumping. 400
To explore this idea further, we assessed how loss of Pxt affects the level and activity of 401 non-muscle Myosin II. While immunoblotting for MRLC was unsuccessful, immunoblots for 402
Zipper, the Drosophila Myosin Heavy Chain, reveal that non-muscle Myosin II levels are 403 unchanged when PGs are lost ( Figure 4B ). Next, we examined MRLC by immunofluorescence 404 (Majumder et al., 2012; Aranjuez et al., 2016) ; MRLC localization is dependent on its activation 405 by phosphorylation (Vicente-Manzanares et al., 2009). During S10B, active MRLC is enriched 406 at the nurse cell membranes, with the strongest staining in the posterior nurse cells ( Figure 4C -407 C'). When Pxt is lost, active MRLC no longer exhibits the posterior enrichment, and it has a 408 patchy appearance at the nurse cell membranes ( Figure 4D-D') . This difference is not due to 409 cortical actin defects, as phalloidin-labeled cortical F-actin is present in areas of low active 410 MRLC in pxt mutants ( Figure 4D " compared to C"). These data suggest PGs regulate non-411 muscle Myosin II activity to mediate nurse cell contractility. 412
Conclusion 413
The results of this pharmaco-genetic interaction screen support a model in which PG 414 signaling regulates the localization and/or activity of multiple actin binding proteins to 415 coordinate the actin remodeling events during S10B-11 that are required for female fertility. and Cooley, 1994). Reduced levels of Fascin, Ena, and Cp strongly sensitize S10B follicles to 423 the effects of COX inhibition (Table 1 and Figures 2-3) . However, not all proteins required for 424 parallel actin filament bundle formation during S10B exhibit an interaction in our pharmaco-425 genetic interaction screen, as reduced levels of Villin (Groen et al., 2012) or Profilin fail to 426 modify follicle sensitivity to COX inhibition (Table 1 and Figure 2) . These data suggest PG 427 signaling regulates a specific subset of actin binding proteins to promote actin filament bundle 428 formation during Drosophila oogenesis. 429
In addition to promoting actin filament bundle formation during S10B, our data also 430 suggest PG signaling is required to promote nurse cell contractility during S11. During nurse cell 431 dumping (S11), the contractile force required to transfer the nurse cell cytoplasm to the oocyte is 432 generated through non-muscle Myosin II-dependent contraction of the nurse cell cortical actin 433 (Wheatley et al., 1995) . Reduced levels of MRLC strongly enhance follicle sensitivity to the 434 effects of COX inhibition and loss of Pxt results in decreased active MRLC at the nurse cell 435 membranes (Table 1 and images of S10B-S14 Drosophila follicles taken using a stereo dissecting scope; anterior is at the 467 top. Red asterisks indicate the oocyte, yellow brackets mark the nurse cells, and white arrows 468 indicate the dorsal appendages. In the IVEM assay, follicles that remain in S10B-11 are 469 considered undumped, whereas follicles that have reached S12-14 are considered dumped. B-D. 470
Diagrams illustrating the rationale behind the pharmaco-genetic interaction screen. If a 471 particular actin-binding protein is positively regulated by PG signaling to promote actin 472 remodeling during S10B, then heterozygosity for a strong allele of that actin-binding protein 473 would be expected to enhance follicle sensitivity to COX inhibition, resulting in an expected 474 dumping index (% dumping in 1.5mM aspirin/%dumping in control) of less than 0.5 (B). If a 475 particular actin-binding protein is negatively regulated by PG signaling to promote actin 476 remodeling during S10B, then heterozygosity for a strong allele of that actin-binding protein 477 would be expected to suppress follicle sensitivity to COX inhibition, resulting in an expected 478 dumping index greater than 0.5 (C). Reduced levels of an actin-binding protein that is not a 479 downstream target of PG signaling during S10B would not be expected to modify follicle 480 sensitivity to COX inhibition, resulting in an expected dumping index of ~0.5 (D). Heterozygosity for a P element insertion into the locus of the alpha-subunit of Capping protein 518 (cpa KG02261 ), and two hypomorphic allele of the beta-subunit of Capping protein (cpb 6.15 and 519 cpb F19 ) significantly enhance the ability of 1.5mM aspirin to block nurse cell dumping compared 520 to wild-type controls (D). n's are indicated in Table 1 For this genotype, both experimental replicates were performed simultaneously and share a common wild-type control (wild-type control; n=1). f For this genotype, two experimental replicates were performed simultaneously and share a common wild-type control (wild-type; n=2).
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